Department of Pediatrics, Columbia University, New York, New York, USA.
Department of Neurology, NYU Grossman School of Medicine, New York, New York, USA.
Am J Med Genet A. 2024 Jul;194(7):e63578. doi: 10.1002/ajmg.a.63578. Epub 2024 Feb 29.
FEZF2 encodes a transcription factor critical to neurodevelopment that regulates other neurodevelopment genes. Rare variants in FEZF2 have previously been suggested to play a role in autism, and cases of 3p14 microdeletions that include FEZF2 share a neurodevelopmental phenotype including mild dysmorphic features and intellectual disability. We identified seven heterozygous predicted deleterious variants in FEZF2 (three frameshifts, one recurrent missense in two independent cases, one nonsense, and one complete gene deletion) in unrelated individuals with neurodevelopmental disorders including developmental delay/intellectual disability, autism, and/or attention-deficit/hyperactivity. Variants were confirmed to be de novo in five of seven cases and paternally inherited from an affected father in one. Predicted deleterious variants in FEZF2 may affect the expression of genes that are involved in fate choice pathways in developing neurons, and thus contribute to the neurodevelopmental phenotype. Future studies are needed to clarify the mechanism by which FEZF2 leads to this neurodevelopmental disorder.
FEZF2 编码一种对神经发育至关重要的转录因子,它调节其他神经发育基因。FEZF2 的罕见变异先前被认为在自闭症中起作用,并且包括 FEZF2 的 3p14 微缺失病例具有神经发育表型,包括轻度畸形特征和智力障碍。我们在具有神经发育障碍的无关个体中鉴定出七个杂合的预测有害 FEZF2 变异(三个移码,两个独立病例中的一个复发性错义,一个无义,和一个完整基因缺失),包括发育迟缓/智力障碍、自闭症和/或注意力缺陷/多动障碍。在七个病例中的五个中,变异被确认为从头开始,在一个病例中从受影响的父亲遗传而来。FEZF2 的预测有害变异可能影响参与发育神经元命运选择途径的基因的表达,从而导致神经发育表型。需要进一步的研究来阐明 FEZF2 导致这种神经发育障碍的机制。